Concepedia

Mengxing Li

ML

Statistics

Publications

11

Citations

301

H-Index

11

Active since

2019

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Central South University

Xiangya Hospital Central South University

Mays Cancer Center at UT Health San Antonio

The University of Texas at San Antonio

Mengxing Li is an author at The University of Texas at San Antonio Health Science Center specializing in oncology, medicine, and molecular oncology.

Publications per year

2019–2025

11

Publications

11

Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways

Mei Zhou, Gangadhara R. Sareddy, Mengxing Li et al. · Scientific Reports · 2019 · 47 citations · Full text

Medicine, Molecular Biology, Oncology +17

PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer

Yizeng Fan, Yuzhao Wang, Weichao Dan et al. · Nature Cell Biology · 2025 · 41 citations

Medicine, Molecular Biology, Oncology +10

Itaconate transporter SLC13A3 confers immunotherapy resistance via alkylation-mediated stabilization of PD-L1

Yizeng Fan, Weichao Dan, Yuzhao Wang et al. · Cell Metabolism · 2025 · 38 citations · Full text

Medicine, Immunology, Oncology +17

Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress

Xihui Liu, Suryavathi Viswanadhapalli, Shourya Kumar et al. · Nature Cancer · 2022 · 33 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers

Suryavathi Viswanadhapalli, Shihong Ma, Gangadhara R. Sareddy et al. · Breast Cancer Research · 2019 · 26 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 11